- About Us
- Advertise
- Editorial Information
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Susan Haigney
Articles
The Impact of Insufficient Oversight
BioPharm International asked Vincent Colicchio, vice president, supply chain and external manufacturing at Dr. Reddy’s Laboratories, about how a lack of proper supplier oversight can impact the pharmaceutical industry and the drug supply chain.
Balancing Pressing Priorities
CMOs and CDMOs adjust business processes as demand for COVID-19 treatments and non-pandemic related therapies puts pressure on the bio/pharma industry.
Ensuring Contract Manufacturing Facilities Are Up to Speed
The COVID-19 pandemic has triggered additional considerations to supplier oversight of contract manufacturing facilities.
FDA 2021 Guidance Agenda Sees Focus on Generics
The agency’s focus appears to be on generic drugs for the upcoming year.